Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2487566 | Journal of Pharmaceutical Sciences | 2007 | 12 Pages |
Abstract
Phospholipids have been extensively evaluated as an anchor for both PEGylation and receptorâtargeting in liposomal formulations. However, cholesterol, another important component in biomembranes, has not been fully investigated as an alternative anchor. In this study, the potential role of cholesterol for anchoring PEG and folate was investigated. Cholesterol derivatives were synthesized for PEGylation (mPEGâcholesterol) and folate receptor (FR) targeting (folateâPEGâcholesterol) and incorporated into the bilayer of FRâtargeted liposomal doxorubicin. The colloidal stability of these cholesterol derivativeâcontaining liposomes was superior to nonâPEGylated liposomes, indicating that steric barrier provided by mPEGâcholesterol can efficiently inhibit aggregation of liposomes. FRâtargeting activity of these liposomes was demonstrated by in vitro cellâbinding studies on FRâoverexpressing KB cells. In addition, in vivo circulation of cholesterolâanchored liposomes was prolonged compared to nonâPEGylated liposomes. These studies suggest that cholesterol is a viable bilayer anchor for synthesis of PEGylated and FRâtargeted liposomes. © 2007 WileyâLiss, Inc. and the American Pharmacists Association J Pharm Sci 96: 2424-2435, 2007
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Xiaobin B. Zhao, Natarajan Muthusamy, John C. Byrd, Robert J. Lee,